The anti‐apoptosis function of Bcl‐2 can be genetically separated from its inhibitory effect on cell cycle entry

No abstract is available for this paper.

• Publication year

  1997

• Venue

  EMBO Journal

• Publication date

  1997-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/emboj/16.15.4628PMID 9303307PMCID PMC1170089
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of apoptosis

  1999cited by this paper
• Expression of a bcl-2 transgene reduces proliferation and slows turnover of developing B lymphocytes in vivo.

  1997cited by this paper
• Bcl-xL forms an ion channel in synthetic lipid membranes

  1997cited by this paper
• Interaction and Regulation of Subcellular Localization of CED-4 by CED-9

  1997cited by this paper
• Interaction between the C. elegans cell-death regulators CED-9 and CED-4

  1997cited by this paper
• Bcl-2, Bcl-xL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death

  1997cited by this paper
• bcl-2 transgene expression promotes survival and reduces proliferation of CD3-CD4-CD8- T cell progenitors.

  1997cited by this paper
• Interaction of CED-4 with CED-3 and CED-9: A Molecular Framework for Cell Death

  1997cited by this paper
• Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of Apoptosis

  1997cited by this paper
• A license to kill.

  1996cited by this paper
• Evidence for alpha-helical conformation of an essential N-terminal region in the human Bcl2 protein.

  1996cited by this paper
• Bax alpha perturbs T cell development and affects cell cycle entry of T cells.

  1996cited by this paper
• The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/M

  1996cited by this paper
• Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death

  1996influential reference
• Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene.

  1996influential reference
• Induction of Apoptosis by Human Nbk / Bik , a BH 3-Containing Protein That Interacts with E 1 B 19 K

  1996cited by this paper
• Human ICE/CED-3 protease nomenclature.

  1996cited by this paper
• Life, death, and the pursuit of apoptosis.

  1996cited by this paper
• Evidence for α-Helical Conformation of an Essential N-terminal Region in the Human Bcl2 Protein*

  1996cited by this paper
• Abrogation of p53-induced G1 arrest by the HPV 16 E7 protein does not inhibit p53-induced apoptosis.

  1996cited by this paper
• Functional dissection of the human Bc12 protein: sequence requirements for inhibition of apoptosis

  1996cited by this paper
• Unmasking of a proliferation-restraining activity of the anti-apoptosis protein EBV BHRF1.

  1996influential reference
• A Peptide Sequence from Bax That Converts Bcl-2 into an Activator of Apoptosis (*)

  1996cited by this paper
• Molecular thanatopsis: a discourse on the BCL2 family and cell death.

  1996cited by this paper
• Proapoptotic Protein Bax Heterodimerizes with Bcl-2 and Homodimerizes with Bax via a Novel Domain (BH3) Distinct from BH1 and BH2 (*)

  1996cited by this paper
• The Caenorhabditis elegans cell-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease.

  1996cited by this paper
• Deletion of a nonconserved region of Bcl-2 confers a novel gain of function: suppression of apoptosis with concomitant cell proliferation.

  1996influential reference
• BID: a novel BH3 domain-only death agonist.

  1996cited by this paper
• bcl-w, a novel member of the bcl-2 family, promotes cell survival.

  1996influential reference
• The cell death inhibitor Bcl‐2 and its homologues influence control of cell cycle entry.

  1996cited by this paper
• X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death

  1996cited by this paper
• Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation.

  1996influential reference
• Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival.

  1996cited by this paper
• Diminished Cell Proliferation Associated with the Death-protective Activity of Bcl-2*

  1996cited by this paper
• Phosphorylation of Bcl-2 Protein and Association with p21Ras in Ras-induced Apoptosis (*)

  1996cited by this paper
• Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K

  1996cited by this paper
• Apoptosis suppressing protein bcl‐2 is expressed in well‐differentiated breast carcinomas with favourable prognosis

  1995cited by this paper
• Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak

  1995cited by this paper
• A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions.

  1995cited by this paper
• Regulation of lymphocyte survival by the bcl-2 gene family.

  1995cited by this paper
• Regulators of cell death.

  1995cited by this paper
• Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins.

  1995cited by this paper
• R-Ras promotes apoptosis caused by growth factor deprivation via a Bcl- 2 suppressible mechanism

  1995cited by this paper
• Peripheral T-cell lymphoma in lckpr-bcl-2 transgenic mice.

  1995cited by this paper
• Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K

  1995cited by this paper
• Induction of apoptosis by the Bcl-2 homologue Bak

  1995cited by this paper
• Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein

  1995cited by this paper
• Bcl‐2 and Fas/APO‐1 regulate distinct pathways to lymphocyte apoptosis.

  1995cited by this paper
• ICE-like proteases in apoptosis.

  1995cited by this paper
• Structure-Function Analysis of Bcl-2 Protein

  1995cited by this paper
• Inactivation of Bcl-2 by phosphorylation.

  1995cited by this paper
• Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways.

  1994cited by this paper
• The protein bcl-2 alpha does not require membrane attachment, but two conserved domains to suppress apoptosis

  1994influential reference
• BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax

  1994influential reference
• The protein product of the oncogene bcl-2 is a component of the nuclear envelope, the endoplasmic reticulum, and the outer mitochondrial membrane.

  1994cited by this paper
• Bcl-2 and the regulation of programmed cell death

  1994cited by this paper
• R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells.

  1994cited by this paper
• DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2.

  1994cited by this paper
• Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase.

  1994cited by this paper
• Oncogenic activation of human R-ras by point mutations analogous to those of prototype H-ras oncogenes.

  1994cited by this paper
• Growth factor starvation of bcl-2 overexpressing murine bone marrow cells induced refractoriness to IL-3 stimulation of proliferation.

  1994cited by this paper
• Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells

  1994cited by this paper
• Programmed cell death in Caenorhabditis elegans.

  1994cited by this paper
• Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins.

  1994cited by this paper
• Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins.

  1994cited by this paper
• Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

  1993influential reference
• E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells.

  1993cited by this paper
• The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme

  1993cited by this paper
• Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.

  1993influential reference
• bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

  1993cited by this paper
• The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme.

  1993cited by this paper
• Bcl-2 associates with the ras-related protein R-rasp23

  1993cited by this paper
• Gene splicing by overlap extension.

  1993cited by this paper
• Cooperative interaction between c-myc and bcl-2 proto-oncogenes

  1992cited by this paper
• Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas.

  1992influential reference
• A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.

  1991influential reference
• Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)

  1991cited by this paper
• Mechanisms and functions of cell death.

  1991cited by this paper
• Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.

  1990cited by this paper
• pEF-BOS, a powerful mammalian expression vector.

  1990influential reference
• Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation.

  1990cited by this paper
• Simultaneous fluorescent labeling of DNA, RNA, and protein.

  1990cited by this paper
• The bcl-2 gene, follicular lymphoma, and Hodgkin's disease.

  1990cited by this paper
• Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2

  1990cited by this paper
• A Short Polypeptide Marker Sequence Useful for Recombinant Protein Identification and Purification

  1988cited by this paper
• Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

  1988influential reference
• Complexes of polyoma virus medium T antigen and cellular proteins.

  1985cited by this paper
• Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.

  1984cited by this paper
• Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics

  1972cited by this paper
• On the regulation of cell division.

  1966influential reference
• in the protein

  year unknowncited by this paper

• Druglike Molecular Degraders of the Oncogenic RNA-Binding Protein HuR

  2025cites this paper
• BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism

  2024cites this paper
• Androgens Modulate Bcl-2 Agonist of Cell Death (BAD) Expression and Function in Breast Cancer Cells

  2023cites this paper
• N6-Methyladenosine Methylation of mRNA in Cell Apoptosis

  2023cites this paper
• Bcl-xL enforces a slow-cycling state necessary for survival in the nutrient-deprived microenvironment of pancreatic cancer.

  2022cites this paper
• Integrated chemical profiling, network pharmacology and pharmacological evaluation to explore the potential mechanism of Xinbao pill against myocardial ischaemia–reperfusion injury

  2022cites this paper
• Stress Relief Techniques: p38 MAPK Determines the Balance of Cell Cycle and Apoptosis Pathways

  2021cites this paper
• Identifying the Chemical Profile and Pharmacological Mechanism of Xinbao Pill against Myocardial Ischemia-Reperfusion Injury Using Ultra-Fast Liquid Chromatography-Quadrupole-Time-Of-Flight Tandem Mass Spectrometry Coupled with Network Pharmacology-Based Investigation

  2021cites this paper
• The pan-Bcl-2 inhibitor obatoclax promotes differentiation and apoptosis of acute myeloid leukemia cells

  2020cites this paper
• Bmf Facilitates Protein Degradation and Reduces Beclin1 Ubiquitination to Inhibit Autophagy Independent of mTOR

  2020cites this paper
• IL-22 in hepatocyte’s survival of Pakistani patients with end stage liver disease: an insight into IL 22 mediated hepato-regenerative pathway

  2019cites this paper
• Sunset Yellow and Allura Red modulate Bcl2 and COX2 expression levels and confer oxidative stress-mediated renal and hepatic toxicity in male rats

  2018cites this paper
• BCL2 Inhibitors: Insights into Resistance

  2018cites this paper
• Genetic variants in IL15 promoter affect transcription activity and intramuscular fat deposition in longissimus dorsi muscle of pigs

  2018cites this paper
• ZNF509S1 downregulates PUMA by inhibiting p53K382 acetylation and p53-DNA binding.

  2017cites this paper
• Non-canonical roles of Bcl-2 and Bcl-xL proteins: relevance of BH4 domain.

  2017cites this paper
• 2 Resistance to Apoptosis in Cancer Therapy

  2017cites this paper
• Role of β-Interferon Inducer (DEAE-Dextran) in Tumorigenesis by VEGF and NOTCH1 Inhibition along with Apoptosis Induction

  2017cites this paper
• FoxO3a reactivation restores the sensitivity to the antiestrogen treatment in tamoxifen resistant breast cancer

  2017cites this paper
• Non-apoptotic functions of BCL-2 family proteins

  2017cites this paper
• MODULATING SURVIVIN APOPTOSIS PATHWAYS

  2017cites this paper
• Ligand activated progesterone receptor B drives autophagy-senescence transition through a Beclin-1/Bcl-2 dependent mechanism in human breast cancer cells

  2016cites this paper
• Affinity purification-mass spectrometry analysis of bcl-2 interactome identified SLIRP as a novel interacting protein

  2016cites this paper
• A new approach to high risk pediatric acute lymphoblastic leukemia

  2016cites this paper
• Bcl-2 family proteins: master regulators of cell survival

  2016cites this paper
• Cytotoxic effects of novel small molecules on PC3 prostate cancer cells

  2016cites this paper
• Functional Implications of the spectrum of BCL2 mutations in Lymphoma.

  2016cites this paper
• Activation of NQO1 in NQO1*2 polymorphic human leukemic HL-60 cells by diet-derived sulforaphane

  2016cites this paper
• Changes in Expression of Genes Representing Key Biologic Processes after Neoadjuvant Chemotherapy in Breast Cancer, and Prognostic Implications in Residual Disease

  2016cites this paper
• Dynamic Bcl-xL (S49) and (S62) Phosphorylation/Dephosphorylation during Mitosis Prevents Chromosome Instability and Aneuploidy in Normal Human Diploid Fibroblasts

  2016cites this paper
• Roles of BCL-2 and BAD in Breast Cancer

  2015cites this paper
• BCL-2 family protein, BAD is down-regulated in breast cancer and inhibits cell invasion.

  2015cites this paper
• Phytopharmaceuticals in Cancer Chemoprevention and Therapy Chapter 12: NADH in Cancer Prevention and Therapy

  2015cites this paper
• Obatoclax Induces G1/G0‐Phase Arrest via p38/p21waf1/Cip1 Signaling Pathway in Human Esophageal Cancer Cells

  2014cites this paper
• A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum.

  2014cites this paper
• Adoptiver T-Zell-Transfer zur Therapie hochmaligner Lymphome im c-myc-transgenen Mausmodell

  2014cites this paper
• Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity.

  2014cites this paper
• The anti-proliferation and pro-apoptosis of hydroxybenzoate calcium complexes in HT-1080 human fibrosarcoma cells

  2014cites this paper
• The Effects of Bcl-2 and Bcl-XL Expression on the Radiation Response of MCF-10A Cells

  2013cites this paper
• survival in T cells A1 is a growth-permissive anti-apoptotic factor mediating post-activation

  2013cites this paper
• Non-apoptotic roles of Bcl-2 family: the calcium connection.

  2013cites this paper
• Mimicking pregnancy as a strategy for breast cancer prevention.

  2013cites this paper
• Expression of survivin, Bcl-2 and Bax proteins in the domestic cat (Felis catus) endometrium during the oestrus cycle.

  2013cites this paper
• Crosstalk Between VEGF and Bcl-2 in Tumor Progression and Angiogenesis

  2013cites this paper
• The development of tissue explant and embryonic stem cell derived models to investigate the molecular and cellular mechanisms that coordinate vertebrate haematopoiesis and angiogenesis

  2013cites this paper
• Removal of the BH4 domain from Bcl-2 protein triggers an autophagic process that impairs tumor growth.

  2013cites this paper
• Sheeppox Virus SPPV14 Encodes a Bcl-2-Like Cell Death Inhibitor That Counters a Distinct Set of Mammalian Proapoptotic Proteins

  2012cites this paper
• Phospho-Bcl-xL(Ser62) plays a key role at DNA damage-induced G2 checkpoint

  2012cites this paper
• A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER‐positive breast cancer

  2012cites this paper
• The secret life of Bcl-2: apoptosis-independent inhibition of DNA repair by Bcl-2 family members.

  2012cites this paper
• Sunitinib malate in solitary fibrous tumor (SFT).

  2012cites this paper
• The Role of Bcl-2 Family Proteins in Therapy Responses of Malignant Astrocytic Gliomas: Bcl2L12 and Beyond

  2012cites this paper
• Drug Resistance in Leukemia and Lymphoma III

  2012cites this paper
• Non‐apoptotic functions of apoptosis‐regulatory proteins

  2012cites this paper
• High-grade Sarcomatous Overgrowth in Solitary Fibrous Tumors: A Clinicopathologic Study of 10 Cases

  2012cites this paper
• Immunohistochemical study of BCL-2, PCNA and VIMENTIN markers in oral and laryngeal squamous cell carcinoma (Comparative study)

  2011cites this paper
• Enforced expression of the apoptosis inhibitor Bcl-2 ablates tolerance induction in DNA-reactive B cells through a novel mechanism.

  2011cites this paper
• miR-125b and miR-155 Contribute to BCL2 Repression and Proliferation in Response to CD40 Ligand (CD154) in Human Leukemic B-cells*

  2011cites this paper
• Improving Developmental Competence of Murine Preimplantation Embryos by Supplementation of Anti-apoptotic Peptides

  2011cites this paper
• From cell biology to therapy: ENMD-2076 in the treatment of multiple myeloma

  2011cites this paper
• Sensory Neuropathy Attributable to Loss of Bcl-w

  2011cites this paper
• Activation of Multiple Apoptotic Pathways in Human Nasopharyngeal Carcinoma Cells by the Prenylated Isoflavone, Osajin

  2011cites this paper
• Bcl-2 family members regulate the sensitivity to 2-deoxy-D-glucose in lymphomas

  2011cites this paper
• Overcoming blocks in apoptosis with BH3-mimetic therapy in haematological malignancies

  2011cites this paper
• The biological heterogeneity of oestrogen receptor positive breast cancer and its phenotypic characterisation

  2011cites this paper
• Apoptotic and anti-apoptotic factors in early human mandible development.

  2010cites this paper
• B-cell overexpression of Bcl-2 cooperates with p21 deficiency for the induction of autoimmunity and lymphomas.

  2010cites this paper
• Estrogenic Activity of Coumestrol, DDT, and TCDD in Human Cervical Cancer Cells

  2010cites this paper
• Clinical Relevance of Apoptotic Regulatory Proteins in Colorectal Cancers

  2010cites this paper
• Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.

  2010cites this paper
• G93A SOD1 alters cell cycle in a cellular model of Amyotrophic Lateral Sclerosis.

  2010cites this paper
• Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis.

  2010cites this paper
• Induction of apoptosis by (-)-gossypol-enriched cottonseed oil in human breast cancer cells.

  2010cites this paper
• Apoptosis Signaling: A Means to an End

  2010cites this paper
• Structural Basis for Apoptosis Inhibition by Epstein-Barr Virus BHRF1

  2010cites this paper
• The expression of Bcl‐2 by proliferating cells varies in different categories of B‐cell lymphoma

  2010cites this paper
• Preclinical activity of a novel multiple tyrosine kinase and aurora kinase inhibitor, ENMD‐2076, against multiple myeloma

  2010cites this paper
• Transgenic Bcl-3 slows T cell proliferation

  2009cites this paper
• Biologically distinct conformations of Bcl-x can be resolved using 2D isoelectric focusing.

  2009cites this paper
• BCL2L12A localizes to the cell nucleus and induces growth inhibition through G2/M arrest in CHO cells

  2009cites this paper
• Investigation of the molecular mechanisms regulating growth and recombinant protein productivity in suspension-adapted CHO-K1 cells

  2009cites this paper
• Distinctive cell properties of B cells carrying the BCL2 translocation and their potential roles in the development of lymphoma of germinal center type

  2009cites this paper
• Resveratrol alters proliferative responses and apoptosis in human activated B lymphocytes in vitro.

  2009cites this paper
• Bcl-2 blocks 2-methoxyestradiol induced leukemia cell apoptosis by a p27(Kip1)-dependent G1/S cell cycle arrest in conjunction with NF-kappaB activation.

  2009cites this paper
• The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer.

  2009cites this paper
• Regulation of Apoptosis by the Muscle Regulatory Transcription Factor MyoD

  2009cites this paper
• BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocations

  2009cites this paper
• Novel Bcl-2 Homology-3 Domain-like Sequences Identified from Screening Randomized Peptide Libraries for Inhibitors of the Pro-survival Bcl-2 Proteins*

  2009cites this paper
• Bcl-2 Regulates Proapoptotic Calcium Signals by Interacting with the Inositol 1, 4, 5-Trisphosphate Receptor

  2008cites this paper
• Chemoresistance in gliomas

  2008cites this paper
• Prognostic value of Bcl‐2 in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy

  2008cites this paper
• Impact of Targeting the Adenine- and Uracil-Rich Element of bcl-2 mRNA with Oligoribonucleotides on Apoptosis, Cell Cycle, and Neuronal Differentiation in SHSY-5Y Cells

  2008cites this paper
• Intracellular bacteriolysis triggers a massive apoptotic cell death in Shigella-infected epithelial cells.

  2008cites this paper
• A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation

  2008cites this paper
• ApoG2, a novel inhibitor of antiapoptotic Bcl‐2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenografts

  2008cites this paper
• A survivor hits the breaks.

  2008cites this paper
• p27 Deficiency Cooperates with Bcl-2 but Not Bax to Promote T-Cell Lymphoma

  2008cites this paper
• EGL-1 BH3 mutants reveal the importance of protein levels and target affinity for cell-killing potency

  2008cites this paper
• PACAP and VIP prevent apoptosis in schwannoma cells.

  2008cites this paper
• Perspectives on c-Myc, Cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy.

  2007cites this paper